These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 21798973)

  • 1. Personalised medicine for hypertension.
    Brown MJ
    BMJ; 2011 Jul; 343():d4697. PubMed ID: 21798973
    [No Abstract]   [Full Text] [Related]  

  • 2. JNC-7 versus renin-based strategies for optimal antihypertensive drug treatment. Another look at the evidence.
    Blumenfeld JD
    Am J Hypertens; 2004 Oct; 17(10):1002-4. PubMed ID: 15485767
    [No Abstract]   [Full Text] [Related]  

  • 3. JNC-7 versus renin-based strategies for optimal antihypertensive drug treatment.
    Fuchs FD; Fuchs SC
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):572; author reply 572-3. PubMed ID: 15831371
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma renin activity and systemic arterial hypertension.
    Kirkendall WM; Overturf M
    Mod Concepts Cardiovasc Dis; 1973 Oct; 42(10):47-52. PubMed ID: 4784809
    [No Abstract]   [Full Text] [Related]  

  • 5. ["Individualized antihypertensive therapy. Diuretics degraded as hypertension drugs (interview by Dr. med. Jochen Aumiller)].
    Düsing R
    MMW Fortschr Med; 2011 Dec; 153(51-52):21. PubMed ID: 22263286
    [No Abstract]   [Full Text] [Related]  

  • 6. RGS2 expression and aldosterone: renin ratio modulate response to drug therapy in hypertensive patients.
    Semplicini A; Strapazzon G; Papparella I; Sartori M; Realdi A; Macchini L; Calò LA; Ceolotto G
    J Hypertens; 2010 May; 28(5):1104-8. PubMed ID: 20375904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Review on internal medicine, 1973--nephrology. 5. The renin-angiotensin system (author's transl)].
    Kaneko Y
    Nihon Naika Gakkai Zasshi; 1974 Apr; 63(4):342-52. PubMed ID: 4369667
    [No Abstract]   [Full Text] [Related]  

  • 8. The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine.
    Niizuma S; Nakahama H; Kamide K; Fukuchi K; Iwanaga Y; Nakata H; Yoshihara F; Horio T; Nakamura S; Kawano Y
    Clin Exp Hypertens; 2008 Oct; 30(7):640-7. PubMed ID: 18855267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Renin inhibitors for lowering blood pressure].
    Uhl D
    Med Monatsschr Pharm; 1992 Jun; 15(6):162-4. PubMed ID: 1614365
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hypertension and renin/angiotensin. Physiopathological and therapeutical aspects].
    Jorgensen H
    Tidsskr Nor Laegeforen; 1975 Dec; 95(34-36):1988-91. PubMed ID: 1209575
    [No Abstract]   [Full Text] [Related]  

  • 11. Using plasma renin (PRA) testing to design follow-up drug treatment strategies in hypertensive patients already taking antirenin system drugs.
    Sealey JE; Laragh JH
    Am J Hypertens; 2009 Sep; 22(9):950. PubMed ID: 19701164
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of arterial hypertension patients depending on renin activity].
    Naugol'nova SB; Lapshina LA
    Vrach Delo; 1984 Feb; (2):61-5. PubMed ID: 6372240
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypertension management: differing points of view. Should we routinely measure renin levels to diagnose and treat patients with hypertension? The argument against.
    Weinberger MH
    J Clin Hypertens (Greenwich); 2005 Jan; 7(1):36-7; quiz 38-9. PubMed ID: 15655386
    [No Abstract]   [Full Text] [Related]  

  • 14. The efficacy of aliskiren, a direct renin inhibitor, in the treatment of hypertension.
    Gradman AH; Traub D
    Rev Cardiovasc Med; 2007; 8 Suppl 2():S22-30. PubMed ID: 17401313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Observations with Viskaldix, a combined antihypertensive agent.
    Gyimesi A; Hanyec V; Pocsay G; Lörinczy E; Iványi J
    Ther Hung; 1987; 35(3):147-51. PubMed ID: 3326209
    [No Abstract]   [Full Text] [Related]  

  • 16. Design and optimization of a substituted amino propanamide series of renin inhibitors for the treatment of hypertension.
    Chen A; Bayly C; Bezençon O; Richard-Bildstein S; Dubé D; Dubé L; Gagné S; Gallant M; Gaudreault M; Grimm E; Houle R; Lacombe P; Laliberté S; Lévesque JF; Liu S; MacDonald D; Mackay B; Martin D; McKay D; Powell D; Remen L; Soisson S; Toulmond S
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2204-9. PubMed ID: 20206513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [SP 54 therapy in hypertension. The effect of SP 54 on blood pressure, renin and aldosterone as well as electrolyte balance in patients with hypertension].
    Werning C; Stiel D; Hammann K; Schweikert HU; Fischer N; Siegenthaler W
    Fortschr Med; 1972 Jul; 90(20):785-7. PubMed ID: 5074231
    [No Abstract]   [Full Text] [Related]  

  • 18. Renin reactivity as a determinant of responsiveness to antihypertensive treatment.
    Weber MA; Lopez-Ovejero JA; Drayer JI; Case DB; Laragh JH
    Arch Intern Med; 1977 Mar; 137(3):284-9. PubMed ID: 843146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Potentiation of the antihypertensive effect of captopril by diuretics (author's transl)].
    Waeber B; Brunner HR; Turini GA; Curtet N; Keller I; Gavras H
    Ann Cardiol Angeiol (Paris); 1979; 28(1):9-11. PubMed ID: 219758
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypertension and renal diseases.
    Stegman MR; Batterman B; Fitz A
    J Am Assoc Nephrol Nurses Tech; 1975; 2(2):52-63. PubMed ID: 1044655
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.